Eli Lilly sues clinics for selling fake diabetes drug
Eli Lilly has sued several medical clinics, compounding pharmacies, and medical wellness centers in the US to stop the illegal marketing and sale of products that, according to the company, ”fraudulently claim” to be Eli Lilly’s diabetes drug Mounjaro (tirzepatide).
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.